Form 4 for TTD Trade Desk (The)
Accepted 2025-05-15 00:00:00 ET · period of report 2025-05-13 · accession 0001671933-25-000065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-15 | 2025-05-13 | TTD | WELLS DAVID B | Dir | M - OptEx | $58.28 | +28.6K | 95.6K | +43% | +$1.67M |
| D | 2025-05-15 | 2025-05-13 | TTD | WELLS DAVID B | Dir | S - Sale+OE | $79.88 | -28.6K | 67.0K | -30% | -$2.29M |
| DM | 2025-05-15 | 2025-05-13 | TTD | WELLS DAVID B | Dir | M - OptEx | $0.00 | -28.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-05-13 | M | A | 1,365 | $49.03 | 84,446 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-05-13 | M | A | 6,990 | $58.46 | 73,975 | D | — | — | |
| 3 | Common | Class A Common Stock | 2025-05-13 | M | A | 1,390 | $58.46 | 75,365 | D | — | — | |
| 4 | Common | Class A Common Stock | 2025-05-13 | M | A | 670 | $58.46 | 76,035 | D | — | — | |
| 5 | Common | Class A Common Stock | 2025-05-13 | M | A | 220 | $58.46 | 76,255 | D | — | — | |
| 6 | Common | Class A Common Stock | 2025-05-13 | M | A | 6,826 | $49.03 | 83,081 | D | — | — | |
| 7 | Common | Class A Common Stock | 2025-05-13 | S | D | 28,638 | $79.88 | 66,985 | D | — | — | (F1) These sales represent the aggregate shares from the twelve acquisitions reported above. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.88 to $79.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 8 | Common | Class A Common Stock | 2025-05-13 | M | A | 655 | $49.03 | 85,101 | D | — | — | |
| 9 | Common | Class A Common Stock | 2025-05-13 | M | A | 218 | $49.03 | 85,319 | D | — | — | |
| 10 | Common | Class A Common Stock | 2025-05-13 | M | A | 7,282 | $66.26 | 92,601 | D | — | — | |
| 11 | Common | Class A Common Stock | 2025-05-13 | M | A | 1,374 | $66.26 | 93,975 | D | — | — | |
| 12 | Common | Class A Common Stock | 2025-05-13 | M | A | 1,374 | $66.26 | 95,349 | D | — | — | |
| 13 | Common | Class A Common Stock | 2025-05-13 | M | A | 274 | $66.26 | 95,623 | D | — | — | |
| 14 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 1,365 | $0.00 | 0 | D | $49.03 · — to 2032-05-26 | 1,365 Class A Common Stock | (F10) The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| 15 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 274 | $0.00 | 0 | D | $66.26 · — to 2033-05-25 | 274 Class A Common Stock | (F15) The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| 16 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 1,374 | $0.00 | 0 | D | $66.26 · — to 2033-05-25 | 1,374 Class A Common Stock | (F14) The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| 17 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 1,374 | $0.00 | 0 | D | $66.26 · — to 2033-05-25 | 1,374 Class A Common Stock | (F13) The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| 18 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 7,282 | $0.00 | 0 | D | $66.26 · — to 2033-05-25 | 7,282 Class A Common Stock | (F13) The option was granted on May 25, 2023. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| 19 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 6,990 | $0.00 | 0 | D | $58.46 · — to 2031-05-27 | 6,990 Class A Common Stock | (F3) This option was previously reported as covering 699 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. (F4) The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| 20 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 1,390 | $0.00 | 0 | D | $58.46 · — to 2031-05-27 | 1,390 Class A Common Stock | (F5) This option was previously reported as covering 139 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. (F4) The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| 21 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 670 | $0.00 | 0 | D | $58.46 · — to 2031-05-27 | 670 Class A Common Stock | (F6) This option was previously reported as covering 67 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. (F7) The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| 22 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 220 | $0.00 | 0 | D | $58.46 · — to 2031-05-27 | 220 Class A Common Stock | (F8) This option was previously reported as covering 22 shares at an exercise price of $584.58 per share, but was adjusted to reflect a 10-for-1 stock split effective June 16, 2021. (F9) The option was granted on May 27, 2021. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |
| 23 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 6,826 | $0.00 | 0 | D | $49.03 · — to 2032-05-26 | 6,826 Class A Common Stock | (F10) The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the board of directors immediately prior to such date. |
| 24 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 655 | $0.00 | 0 | D | $49.03 · — to 2032-05-26 | 655 Class A Common Stock | (F11) The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the audit committee immediately prior to such date. |
| 25 | Derivative | Stock Option (Right to Buy) | 2025-05-13 | M | D | 218 | $0.00 | 0 | D | $49.03 · — to 2032-05-26 | 218 Class A Common Stock | (F12) The option was granted on May 26, 2022. The shares subject to the option vested in four equal installments at the earlier of, for each such installment, (i) the date of the Issuer's applicable regularly scheduled quarterly Corporate Board meeting for the next four quarters from the date of grant or (ii) the date of each of the next four corresponding quarterly anniversaries of the date of grant, provided all then unvested shares vested in full on the date of the Issuer's next annual meeting of stockholders, all subject to the Reporting Person's continuous service as a member of the compensation committee immediately prior to such date. |